Sonoco Products director Pamela Lewis received 777 derivative securities at $48.43 per share on September 10, 2026. The award lifted her resulting derivative-securities holding to 70,478, with the transaction equal to about 1.1% of that holding, giving investors a precise view of the disclosed award and ownership context.
Key Highlights
- Pamela Lewis held 70,478 derivative securities after the transaction.
- The award represented about 1.1% of her resulting derivative-securities holding.
- Transaction code A classified the transaction as an award or grant.
Sonoco Products Co. (NYSE: SON) awarded director Pamela Lewis 777 derivative securities at $48.43 per share on September 10, 2026.
Derivative Award Set at $48.43 Per Share
The 777 derivative securities were issued at $48.43 per share. Pamela Lewis’s resulting position in Sonoco Products stood at 70,478 derivative securities after the transaction. The disclosed transaction represented about 1.1% of her resulting derivative-securities holding.
FAQs
Q: What did Pamela Lewis receive from Sonoco Products?
A: Sonoco Products director Pamela Lewis received 777 derivative securities at $48.43 per share on September 10, 2026. The transaction was classified as an award or grant.
Q: How many derivative securities did Pamela Lewis hold afterward?
A: Pamela Lewis’s resulting derivative-securities holding was 70,478 after the Sonoco Products transaction. The award represented about 1.1% of that resulting position.
Q: What does transaction code A mean for Sonoco Products stock?
A: Transaction code A identifies an award or grant in SEC transaction reporting. For Sonoco Products, the code accompanied Pamela Lewis’s receipt of derivative securities.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.